STOCKHOLDERS’ AGREEMENTStockholders Agreement • June 24th, 2022 • Impact Biomedical Inc. • Pharmaceutical preparations • Nevada
This STOCKHOLDERS’ AGREEMENT (this “Agreement”) is made and entered into effective as of December ____, 2020, among IMPACT BIOLIFE SCIENCE, INC., a Nevada corporation, (the “Company”) and all of the Company’s stockholders, as listed on the signature page hereto (individually, a “Stockholder” and collectively, the “Stockholders”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • June 24th, 2022 • Impact Biomedical Inc. • Pharmaceutical preparations • New York
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of March 15, 2021, is entered into between Vivacitas Oncology Inc., with a business address at 1990 N. California Boulevard 8th Floor Walnut Creek, CA 94596 (the “Seller”), and SeD BioMedical International, Inc., a wholly owned subsidiary of Impact BioMedical Inc. and an indirect wholly owned subsidiary of Document Security Systems, Inc., a business address at 200 Canal View Blvd, Suite 104 Rochester, NY14623 (the “Buyer”).
AmENDMENT NO. 2 TOStockholders’ Agreement • June 24th, 2022 • Impact Biomedical Inc. • Pharmaceutical preparations • Nevada
THIS AMENDMENT NO. 2 (this “Amendment”), dated as of this ____ day of August, 2020, amending that certain Stockholders’ Agreement, dated April 26, 2017 (the “Stockholders’ Agreement”), as amended on May 22, 2018, is entered into by and among Global BioLife, Inc. a Nevada corporation (the “Company”), and Global BioMedical, Inc., Holista Colltech Limited, and GRDG Sciences, LLC (each a “Stockholder” and collectively, the “Stockholders”).
